Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Topical finasteride helps regrow hair and reduce balding without side effects.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

No link found between specific genes and female pattern hair loss.

Hormones and genes affect hair growth and male baldness.

The hair serum significantly improved hair growth and reduced hair fall without causing any skin issues.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Certain sex hormones and antiandrogens can either slow down or speed up the growth of human hair follicle cells depending on their concentration.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The mouse models are effective for testing new hair loss treatments.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Hair loss in young men in Central India is linked to severe heart disease.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.